NE9.F NEURONES SA NOM. EO 040
- Market cap
- EUR 960M
- P/E
- 17.7x
- P/B
- 2.57x
- ROE
- 13.0%
- Dividend yield
- 3.30%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is NE9.F undervalued?
Graham numberNE9.F trades 41.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
NEURONES SA NOM. EO 040 fundamental analysis
No fundamental analysis for NEURONES SA NOM. EO 040 yet.
NEURONES SA NOM. EO 040 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About NEURONES SA NOM. EO 040
Neurones S.A. provides infrastructure, application, and consulting services in France and internationally. The company offers infrastructure automation, DevOps, cybersecurity, user support, digital workspace, and IT service management, as well as public, private, and hybrid clouds. It also provides digital, UX/UI, mobility,data, and artificial intelligence; SAP integration deployment of new modules and applications; BPM, RPA, dematerialization, and archiving; IT training; an…
Full company profileNEURONES SA NOM. EO 040 financial statements
NEURONES SA NOM. EO 040 annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 580M | 665M | 741M | 810M | 857M |
| Gross Profit | 348M | 409M | 457M | 506M | 542M |
| Operating Income | 61.6M | 71.9M | 75.0M | 78.0M | 75.8M |
| EBITDA | - | 91.1M | 99.0M | 108M | 106M |
| Net Income | 37.7M | 44.2M | 49.4M | 52.6M | 52.1M |
| EPS | 1.56 | 1.83 | 2.04 | 2.17 | 2.14 |
| Balance Sheet | |||||
| Total Assets | 568M | 616M | 676M | 726M | 749M |
| Total Liabilities | 215M | 241M | 266M | 290M | 284M |
| Shareholders' Equity | 312M | 331M | 356M | 378M | 400M |
| Cash & Short-term Investments | 265M | 272M | 298M | 326M | 341M |
| Cash Flow | |||||
| Operating Cash Flow | 64.5M | 55.0M | 72.1M | 84.4M | 71.3M |
| Capital Expenditure | 6.58M | 10.6M | 18.0M | 12.0M | 10.4M |
| Free Cash Flow | 57.9M | 44.4M | 54.1M | 72.3M | 60.8M |
| Ratios | |||||
| ROE | 12.1% | 13.4% | 13.9% | 13.9% | 13.0% |
| ROA | 6.6% | 7.2% | 7.3% | 7.2% | 7.0% |
| Net Profit Margin | 6.5% | 6.6% | 6.7% | 6.5% | 6.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
NEURONES SA NOM. EO 040 dividends
- Dividend yield
- 3.30%
- Forward dividend
- 1.40 EUR
- Payout ratio
- 60.7%
- Ex-dividend date
- Jun 10, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 31.6M | 1.30 | 60.7% |
| 2024 | EUR 29.1M | 1.20 | 55.4% |
| 2023 | EUR 26.6M | 1.10 | 53.9% |
| 2022 | EUR 24.2M | 1.00 | 54.8% |
| 2021 | EUR 48.4M | 2.00 | 128.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns NEURONES SA NOM. EO 040
- Insiders 70.45%
- Institutions 11.55%
- Public & others 18.00%
- Shares outstanding 23.8M
- Free float 22.8M
NEURONES SA NOM. EO 040 company profile
- Company name
- NEURONES SA NOM. EO 040
- Ticker
- NE9.F
- ISIN
- FR0004050250
- Exchange
- Frankfurt Exchange
- Sector
- Technology
- Industry
- Information Technology Services
- Employees
- 7,329
- Fiscal year end
- December
- Address
- Immeuble ?le Clemenceau 1?, Nanterre, France, 92024
- Phone
- 33 1 41 37 41 37
- Website
- neurones.net
About NEURONES SA NOM. EO 040
Neurones S.A. provides infrastructure, application, and consulting services in France and internationally. The company offers infrastructure automation, DevOps, cybersecurity, user support, digital workspace, and IT service management, as well as public, private, and hybrid clouds. It also provides digital, UX/UI, mobility,data, and artificial intelligence; SAP integration deployment of new modules and applications; BPM, RPA, dematerialization, and archiving; IT training; and market finance. In addition, the company offers strategy consulting, management and digital transformation consulting, digital marketing consulting, and HR transformation consulting services. It serves banking/insurance, services/consumer goods, energy/utilities/healthcare, technology/media/telecoms, industry/construction and civil engineering, and public sector markets. Neurones S.A. was founded in 1984 and is headquartered in Nanterre, France.
NEURONES SA NOM. EO 040 management
5- Mr. Luc de ChammardChairman, CEO & Chief Information Officer · born 1954
- Mr. Bertrand DucurtilCOO, Executive VP, Deputy CEO & Director · born 1960
- Paul-César BonnelAdministrative & Financial Director
- Matthieu VautierChief Marketing Officer
- Pierre-Louis .Chief AI Officer